Examples of Analytical Method Implementation
Recommendation
4-6 March 2025
Management, Supply and Quality Assurance of Clinical Trials
Following the recently introduced new Ph. Eur. chapter 5.26 Implementation of pharmacopoeial procedures (Ph. Eur. 11.0), the EDQM published some examples. The intention is to provide users with practical guidance on how critical factors potentially affecting the Analytical Procedure Performance Characteristics (APPCs) can be identified. However, it is emphasized, that the pre-requisite for the implementation of any analytical procedure is a suitable quality system, which ensures that the requirements set for personnel, premises, and equipment are fulfilled.
Examples for Critical Factor Assessment
The following six examples are provided for the assessment of critical factors associated with the analytical procedure under actual conditions:
- Pharmaceutical ingredient (Mannitol) / Identification by infrared absorption spectrophotometry
- Drug product (Deferiprone tablets) / Related substances test by LC-UV
- Active substance (Benzylpenicillin potassium) / Assay by LC-UV
- Infliximab concentrated solution / Cell-based assay procedures
- Drug Product (Deferiprone oral solution) / Microbial enumeration test
- Active substance (Deferiprone) / Sulfated ash
More information is available in the Examples of implementation of pharmacopoeial procedures according to Chapter 5.26 "Implementation of pharmacopoeial procedures” published in Pharmeuropa Online under Technical Information.
Related GMP News
21.11.2024New GMP Journal Article on Analytical Instrument Qualification and System Validation
21.11.2024FDA Warns Chinese OTC Drug Manufacturer Following Review of Records
21.11.2024The Interplay of Data Governance, Integrity, and Quality in Pharmaceutical Analysis
20.11.2024USP-NF Stimuli Article on Stability of Compounded Preparations
07.11.2024FDA Publishes Guideline on Bioequivalence for Immediate-Release Solid Oral Dosage Forms